243 related articles for article (PubMed ID: 34980591)
1. Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review.
Raj R; Mishra R; Jha N; Joshi V; Correa R; Kern PA
BMJ Open Diabetes Res Care; 2022 Jan; 10(1):. PubMed ID: 34980591
[TBL] [Abstract][Full Text] [Related]
2. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease.
Mayeda L; Katz R; Ahmad I; Bansal N; Batacchi Z; Hirsch IB; Robinson N; Trence DL; Zelnick L; de Boer IH
BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958307
[TBL] [Abstract][Full Text] [Related]
3. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.
Yapanis M; James S; Craig ME; O'Neal D; Ekinci EI
J Clin Endocrinol Metab; 2022 May; 107(6):e2221-e2236. PubMed ID: 35094087
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of association between time in range, a continuous glucose monitoring metric, and cardiac autonomic neuropathy in type 2 diabetes patients.
Karthikeyan A; Ramakrishna MP; Swamy NA; Latha AT
Ann Afr Med; 2024; 23(1):19-24. PubMed ID: 38358166
[TBL] [Abstract][Full Text] [Related]
5. The Correlation between Time in Range and Diabetic Microvascular Complications Utilizing Information Management Platform.
Sheng X; Xiong GH; Yu PF; Liu JP
Int J Endocrinol; 2020; 2020():8879085. PubMed ID: 33381172
[TBL] [Abstract][Full Text] [Related]
6. Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus.
El Malahi A; Van Elsen M; Charleer S; Dirinck E; Ledeganck K; Keymeulen B; Crenier L; Radermecker R; Taes Y; Vercammen C; Nobels F; Mathieu C; Gillard P; De Block C
J Clin Endocrinol Metab; 2022 Jan; 107(2):e570-e581. PubMed ID: 34534297
[TBL] [Abstract][Full Text] [Related]
7. [The appropriate cut-off point of time in range (TIR) for evaluating glucose control in type 2 diabetes mellitus].
Dai DJ; Lu JY; Zhang L; Shen Y; Mo YF; Lu W; Zhu W; Bao YQ; Zhou J
Zhonghua Yi Xue Za Zhi; 2020 Oct; 100(38):2990-2996. PubMed ID: 33086449
[No Abstract] [Full Text] [Related]
8. Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type 2 diabetes patients.
Wang Y; Lu J; Shen Y; Ni J; Zhang L; Lu W; Zhu W; Bao Y; Zhou J
J Diabetes Investig; 2022 Sep; 13(9):1543-1550. PubMed ID: 35435323
[TBL] [Abstract][Full Text] [Related]
9. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Vigersky RA; McMahon C
Diabetes Technol Ther; 2019 Feb; 21(2):81-85. PubMed ID: 30575414
[TBL] [Abstract][Full Text] [Related]
10. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
Beck RW; Bergenstal RM; Cheng P; Kollman C; Carlson AL; Johnson ML; Rodbard D
J Diabetes Sci Technol; 2019 Jul; 13(4):614-626. PubMed ID: 30636519
[TBL] [Abstract][Full Text] [Related]
11. Benefits of the addition of continuous or flash glucose monitoring versus standard practice using self-monitored blood glucose and haemoglobin A1c in the primary care of diabetes mellitus: a systematic review protocol.
Kieu A; Govender RD; Östlundh L; King J
BMJ Open; 2021 Aug; 11(8):e050027. PubMed ID: 34446495
[TBL] [Abstract][Full Text] [Related]
12. Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes.
Yoo JH; Choi MS; Ahn J; Park SW; Kim Y; Hur KY; Jin SM; Kim G; Kim JH
Diabetes Technol Ther; 2020 Oct; 22(10):768-776. PubMed ID: 32167394
[No Abstract] [Full Text] [Related]
13. Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes.
Lu J; Ma X; Shen Y; Wu Q; Wang R; Zhang L; Mo Y; Lu W; Zhu W; Bao Y; Vigersky RA; Jia W; Zhou J
Diabetes Technol Ther; 2020 Feb; 22(2):72-78. PubMed ID: 31524497
[No Abstract] [Full Text] [Related]
14. TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes.
Li F; Zhang Y; Li H; Lu J; Jiang L; Vigersky RA; Zhou J; Wang C; Bao Y; Jia W
Diabetes Res Clin Pract; 2020 Aug; 166():108289. PubMed ID: 32615278
[TBL] [Abstract][Full Text] [Related]
15. Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Lu J; Ma X; Zhou J; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Vigersky RA; Jia W
Diabetes Care; 2018 Nov; 41(11):2370-2376. PubMed ID: 30201847
[TBL] [Abstract][Full Text] [Related]
16. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
18. Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study.
Shah VN; Kanapka LG; Akturk HK; Polsky S; Forlenza GP; Kollman C; Beck RW; Snell-Bergeon JK
Diabetes Technol Ther; 2024 Apr; 26(4):246-251. PubMed ID: 38133643
[No Abstract] [Full Text] [Related]
19. Association of Time in Range levels with Lower Extremity Arterial Disease in patients with type 2 diabetes.
Li J; Li Y; Ma W; Liu Y; Yin X; Xie C; Bai J; Zhang M
Diabetes Metab Syndr; 2020; 14(6):2081-2085. PubMed ID: 33137566
[TBL] [Abstract][Full Text] [Related]
20. The Association Between Continuous Glucose Monitoring-Derived Metrics and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes.
Kim MY; Kim G; Park JY; Choi MS; Jun JE; Lee YB; Jin SM; Hur KY; Kim JH
Diabetes Technol Ther; 2021 Jun; 23(6):434-442. PubMed ID: 33523771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
